
Company valuation, historical trends, and peer comparisons.
According to 10x Genomics, Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 7.60B. This represents a change of 209.33% compared to the average of 2.46B of the last 4 quarters.
The mean historical Enterprise Value of 10x Genomics, Inc. over the last ten years is 5.22B. The current 7.60B Enterprise Value has changed 45.59% with respect to the historical average. Over the past ten years (40 quarters), TXG's Enterprise Value was at its highest in in the June 2021 quarter at 20.96B. The Enterprise Value was at its lowest in in the June 2018 quarter at 0.
Average
5.22B
Median
2.58B
Minimum
573.96M
Maximum
15.93B
Discovering the peaks and valleys of 10x Genomics, Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 431.02%
Maximum Annual Enterprise Value = 15.93B
Minimum Annual Increase = -76.67%
Minimum Annual Enterprise Value = 573.96M
| Year | Enterprise Value | Change |
|---|---|---|
| 2025 | 1.72B | 17.04% |
| 2024 | 1.47B | -76.67% |
| 2023 | 6.29B | 56.36% |
| 2022 | 4.02B | -74.74% |
| 2021 | 15.93B | 16.10% |
| 2020 | 13.72B | 431.02% |
| 2019 | 2.58B | 285.10% |
| 2018 | 671.04M | 16.91% |
The current Enterprise Value of 10x Genomics, Inc. (TXG) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
3.16B
5-year avg
5.89B
10-year avg
5.22B
10x Genomics, Inc.’s Enterprise Value is less than Bio-Techne Corporation (11.44B), less than Agilent Technologies, Inc. (50.98B), less than Illumina, Inc. (35.72B), less than Qiagen N.V. (11.28B), less than Revvity, Inc. (19.43B), greater than Standard BioTools Inc. (-4441391.00), less than Bio-Rad Laboratories, Inc. (10.68B), less than Twist Bioscience Corporation (9.13B), less than Genscript Biotech Corporation (10.29B),
| Company | Enterprise Value | Market cap |
|---|---|---|
| 11.44B | $11.42B | |
| 50.98B | $48.78B | |
| 35.72B | $34.69B | |
| 11.28B | $10.41B | |
| 19.43B | $17.11B | |
| -4441391.00 | $237.50M | |
| 10.68B | $10.00B | |
| 9.13B | $9.15B | |
| 10.29B | $10.12B |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like 10x Genomics, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like 10x Genomics, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Enterprise Value?
How can you use the Enterprise Value?
What is 10x Genomics, Inc.'s Enterprise Value?
What is the highest Enterprise Value for 10x Genomics, Inc. (TXG)?
What is the 3-year average Enterprise Value for 10x Genomics, Inc. (TXG)?
What is the 5-year average Enterprise Value for 10x Genomics, Inc. (TXG)?
How does the current Enterprise Value for 10x Genomics, Inc. (TXG) compare to its historical average?